Scribe Therapeutics Inc. (NASDAQ:SCTX – Get Free Report) major shareholder Bio Fund Ii L.P. Ah bought 333,333 shares of the company’s stock in a transaction that occurred on Monday, July 27th. The shares were acquired at an average cost of $15.00 per share, with a total value of $4,999,995.00. Following the transaction, the insider owned 2,385,075 shares in the company, valued at approximately $35,776,125. This represents a 16.25% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.
Scribe Therapeutics Trading Up 11.1%
NASDAQ SCTX opened at $20.40 on Friday. Scribe Therapeutics Inc. has a one year low of $17.31 and a one year high of $25.49.
Read More
- Five stocks we like better than Scribe Therapeutics
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for Scribe Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scribe Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
